Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1928 1
1929 2
1936 1
1954 1
1965 2
1968 1
1970 2
1972 1
1973 1
1974 1
1975 2
1976 1
1977 2
1978 1
1979 2
1980 6
1981 9
1982 8
1983 6
1984 3
1985 6
1986 5
1987 3
1988 5
1989 6
1990 14
1991 8
1992 6
1993 8
1994 5
1995 8
1996 9
1997 8
1998 8
1999 10
2000 9
2001 15
2002 11
2003 17
2004 19
2005 20
2006 16
2007 21
2008 26
2009 29
2010 37
2011 25
2012 46
2013 40
2014 39
2015 44
2016 53
2017 54
2018 43
2019 57
2020 83
2021 89
2022 58
2023 68
2024 46
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,045 results

Results by year

Filters applied: . Clear all
Page 1
Exploiting the folate receptor α in oncology.
Scaranti M, Cojocaru E, Banerjee S, Banerji U. Scaranti M, et al. Nat Rev Clin Oncol. 2020 Jun;17(6):349-359. doi: 10.1038/s41571-020-0339-5. Epub 2020 Mar 9. Nat Rev Clin Oncol. 2020. PMID: 32152484 Review.
Cephalosporin Allergy: Current Understanding and Future Challenges.
Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, Ein D, Lang DM, Phillips E. Khan DA, et al. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2105-2114. doi: 10.1016/j.jaip.2019.06.001. J Allergy Clin Immunol Pract. 2019. PMID: 31495420 Free PMC article. Review.
Aesthetic Dentistry, Part 1: Our Journeys.
Banerji S, Mehta SB. Banerji S, et al. Prim Dent J. 2023 Jun;12(2):2-3. doi: 10.1177/20501684231178137. Prim Dent J. 2023. PMID: 37313873 No abstract available.
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers.
Banerji U, Dean EJ, Pérez-Fidalgo JA, Batist G, Bedard PL, You B, Westin SN, Kabos P, Garrett MD, Tall M, Ambrose H, Barrett JC, Carr TH, Cheung SYA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Elvin P, Foxley A, Lawrence P, Lindemann JPO, Maudsley R, Pass M, Rowlands V, Rugman P, Schiavon G, Yates J, Schellens JHM. Banerji U, et al. Clin Cancer Res. 2018 May 1;24(9):2050-2059. doi: 10.1158/1078-0432.CCR-17-2260. Epub 2017 Oct 24. Clin Cancer Res. 2018. PMID: 29066505 Clinical Trial.
How many roads lead to cohesinopathies?
Banerji R, Skibbens RV, Iovine MK. Banerji R, et al. Dev Dyn. 2017 Nov;246(11):881-888. doi: 10.1002/dvdy.24510. Epub 2017 May 22. Dev Dyn. 2017. PMID: 28422453 Free article. Review.
1,045 results